p53 defies convention again: a p53 mutant that has lost tumor suppression but still can kill

被引:0
|
作者
Manfredi, James J. [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, Dept Oncol Sci, Tisch Canc Inst, New York, NY 10029 USA
来源
EMBO JOURNAL | 2019年 / 38卷 / 20期
关键词
EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; ABSENCE; RESCUE;
D O I
10.15252/embj.2019103322
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Loss of tumor suppression by the p53 protein involves altered or abrogated transcriptional activity resulting in a failure to mediate wild-type cellular responses including cell cycle arrest, senescence, and apoptosis. Timofeev et al (2019) make the fascinating finding that a novel p53 cooperativity mutation devoid of DNA binding results in no tumor suppression but surprising retention of an apoptotic response to chemotherapy and other treatments. This shows a need for rethinking how mutant p53-driven tumors are treated in the clinic.
引用
收藏
页数:3
相关论文
共 50 条
  • [21] A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis
    Xuetian Yue
    Yuhan Zhao
    Grace Huang
    Jun Li
    Junlan Zhu
    Zhaohui Feng
    Wenwei Hu
    Cell Discovery, 2
  • [22] A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis
    Yue, Xuetian
    Zhao, Yuhan
    Huang, Grace
    Li, Jun
    Zhu, Junlan
    Feng, Zhaohui
    Hu, Wenwei
    CELL DISCOVERY, 2016, 2
  • [23] Assembly of Toxic Amyloid Fibrils of p53 at Physiological Conditions: Is Tumor Mutant of p53 a Prionoid?
    Dinis Ano Bom, Ana Paula
    Sanches, Daniel
    Braga, Carolina
    Gava, Lisandra
    Ramos, Carlos
    Cepeda, Ana
    Levy, Claudia
    Stumbo, Ana
    Gallo, Claudia De Moura
    Cordeiro, Yraima
    Silva, Jerson Lima
    FASEB JOURNAL, 2011, 25
  • [24] Attack of the mutant p53
    Sarah Seton-Rogers
    Nature Reviews Cancer, 2009, 9 : 384 - 385
  • [25] Targeting p53 as a promising therapeutic option for cancer by re-activating the wt or mutant p53's tumor suppression
    Wesierska-Gadek, Jozefa
    FUTURE MEDICINAL CHEMISTRY, 2018, 10 (07) : 755 - 777
  • [26] p53 isoforms can regulate p53 transcriptional activity
    Bourdon, JC
    Fernandes, K
    Murray-Zmijewski, F
    Liu, G
    Diot, A
    Xirodimas, DP
    Saville, MK
    Lane, DP
    GENES & DEVELOPMENT, 2005, 19 (18) : 2122 - 2137
  • [27] Pontin, a novel interactor of mutant p53 that promotes mutant p53 gain of function
    Zhao, Yuhan
    Yue, Xuetian
    Hu, Wenwei
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (02)
  • [28] Gender, mutant p53 and PML: A growing "affaire" in tumor suppression and oncogenesis
    Di Agostino, Silvia
    Strano, Sabrina
    Blandino, Giovanni
    CELL CYCLE, 2013, 12 (12) : 1824 - 1825
  • [29] Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways
    Haupt, Sue
    Raghu, Dinesh
    Haupt, Ygal
    FRONTIERS IN ONCOLOGY, 2016, 6
  • [30] Suppression of p53R2 but not R2 radiosensitizes mutant p53 tumor cells
    Flanagan, Sheryl A.
    Ackroyd, Jeffrey J.
    Mannava, Sudha
    Nikiforov, Mikhail A.
    Shewach, Donna S.
    CANCER RESEARCH, 2014, 74 (19)